List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
905-CL-055A randomized, double-blind, parallel group, placebo controlled,multi-center study of fixed dose combinations of solifenacin succinate(6 mg and 9 mg) with tamsulosin hydrochloride OCAS 0.4 mg andtamsulosin hydrochloride OCAS 0.4 mg monotherapy, in male subjectswith lower urinary tract symptoms (LUTS) associated withbenign prostatic hyperplasia (BPH) with a substantial storage component English


English


905-CL-057An open-label, long term, multi-center study to assess the safety andefficacy of fixed dose combinations of solifenacin succinate (6 mg and 9 mg)with tamsulosin hydrochloride OCAS 0.4 mg, in male subjects with lowerurinary tract symptoms (LUTS) associated with benign prostatichyperplasia (BPH) with a substantial storage component English


English


QUICK SEARCH

USEFUL LINKS